Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023
Mon, December 18, 2023
Fri, December 15, 2023
Thu, December 14, 2023

Derek Archila Maintained (ASND) at Buy with Increased Target to $149 on, Dec 19th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-149-on-dec-19th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $137 to $149 on, Dec 19th, 2023.

Derek has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $116 on, Thursday, November 9th, 2023


These are the ratings of the 2 analyists that currently disagree with Derek


  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $192 on, Wednesday, November 8th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Friday, September 15th, 2023

Publication Contributing Sources